Literature DB >> 33146395

Aetiology of fever in returning travellers and migrants: a systematic review and meta-analysis.

Imogen Buss1, Blaise Genton1,2, Valérie D'Acremont1,2.   

Abstract

BACKGROUND: Numerous publications focus on fever in returning travellers, but there is no known systematic review considering all diseases, or all tropical diseases causing fever. Such a review is necessary in order to develop appropriate practice guidelines.
OBJECTIVES: Primary objectives of this review were (i) to determine the aetiology of fever in travellers/migrants returning from (sub) tropical countries as well as the proportion of patients with specific diagnoses, and (ii) to assess the predictors for specific tropical diseases.
METHOD: Embase, MEDLINE and Cochrane Library were searched with terms combining fever and travel/migrants. All studies focusing on causes of fever in returning travellers and/or clinical and laboratory predictors of tropical diseases were included. Meta-analyses were performed on frequencies of etiological diagnoses.
RESULTS: 10 064 studies were identified; 541 underwent full-text review; 30 met criteria for data extraction. Tropical infections accounted for 33% of fever diagnoses, with malaria causing 22%, dengue 5% and enteric fever 2%. Non-tropical infections accounted for 36% of febrile cases, with acute gastroenteritis causing 14% and respiratory tract infections 13%. Positive likelihood ratios demonstrated that splenomegaly, thrombocytopenia and hyperbilirubinemia were respectively 5-14, 3-11 and 5-7 times more likely in malaria than non-malaria patients. High variability of results between studies reflects heterogeneity in study design, regions visited, participants' characteristics, setting, laboratory investigations performed and diseases included.
CONCLUSION: Malaria accounted for one-fifth of febrile cases, highlighting the importance of rapid malaria testing in febrile returning travellers, followed by other rapid tests for common tropical diseases. High variability between studies highlights the need to harmonize study designs and to promote multi-centre studies investigating predictors of diseases, including of lower incidence, which may help to develop evidence-based guidelines. The use of clinical decision support algorithms by health workers which incorporate clinical predictors, could help standardize studies as well as improve quality of recommendations. © International Society of Travel Medicine 2020. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; Predictor; diagnosis; febrile; guidelines; likelihood ratio; tropical disease

Mesh:

Year:  2020        PMID: 33146395      PMCID: PMC7665639          DOI: 10.1093/jtm/taaa207

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  5 in total

Review 1.  Fever in the Returning Traveler.

Authors:  Dennis Paquet; Laura Jung; Henning Trawinski; Sebastian Wendt; Christoph Lübbert
Journal:  Dtsch Arztebl Int       Date:  2022-06-07       Impact factor: 8.251

2.  High prevalence of malaria in a non-endemic setting among febrile episodes in travellers and migrants coming from endemic areas: a retrospective analysis of a 2013-2018 cohort.

Authors:  Alejandro Garcia-Ruiz de Morales; Covadonga Morcate; Elena Isaba-Ares; Ramon Perez-Tanoira; Jose A Perez-Molina
Journal:  Malar J       Date:  2021-11-27       Impact factor: 2.979

Review 3.  Rickettsiosis in Southeast Asia: Summary for International Travellers during the COVID-19 Pandemic.

Authors:  Thundon Ngamprasertchai; Borimas Hanboonkunupakarn; Watcharapong Piyaphanee
Journal:  Trop Med Infect Dis       Date:  2022-01-27

4.  Malaria Surveillance - United States, 2018.

Authors:  Kimberly E Mace; Naomi W Lucchi; Kathrine R Tan
Journal:  MMWR Surveill Summ       Date:  2022-09-02

5.  Explaining Neighbourhood Variations in the Incidence of Dengue Fever in Jeddah City, Saudi Arabia.

Authors:  Ibrahim Alkhaldy; Ross Barnett
Journal:  Int J Environ Res Public Health       Date:  2021-12-15       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.